Practical Management of Immuno-Oncology (IO) Side Effects

Practical Management of Immuno-Oncology (IO) Side Effects
Video & slides 3 hours £299+VAT
Video & Slides
Thu 17 Mar 2022

Featuring presentation videos and accompanying slides: Attendees were able to engage virtually with other Immuno-Oncology professionals from across the country and increase thier knowledge of myositis, uveitis, thyroiditis and gastrointestinal toxicities secondary to immunotherapy.

If you would like to attend a future event on this topic, please email enquiries@sbk-healthcare.co.uk or telephone 01732 897788, where our customer service team will be happy to assist you. 

With thanks to our conference sponsor:


3 hours Continuing Professional Development

An excellent opportunity to refresh your knowledge with a good balance between science and case studies. This dedicated forum focused on:

  • Developing protocols and improving management of GI side effects
  • Triaging and treating inclusion body myositis (IBM)
  • Assessing and managing uveitis secondary to immunotherapy
  • Recognising and treating thyroiditis secondary to IO

Meet your education and training needs in your own time

Purchase the recording from this study day you will take away ideas from the trailblazers and guidance on how to adapt them for your own service, plus benefit from:

  • 3 CPD hours of presentation and speaker Q&A
  • Featuring engaging video and accompanying slides
  • Available at £299 + VAT for NHS and public sector professionals
  • Download and view in your own time
  • CPD Certificate issued to you after viewing the video

With thanks to the course sponsor

Special thanks to our industry partner Bristol-Myers Squibb.

Introductions, instructions and chair’s opening remarks
Jacqui Warden, Oncology Advanced Nurse Practitioner, Oxford University Hospitals NHS Foundation Trust
Treating adverse effects
Developing protocols and improving management of GI side effects
  • Why do gastrointestinal toxicities present as side effects of immunotherapy?
  • Understanding the severity and when to escalate
  • Protocols to effectively manage toxicity: assessment, intervention, investigations and the MDT approach
Dr Vincent Cheung, Consultant Gastroenterologist, Oxford University Hospitals NHS Foundation Trust
Managing side effects
Assessing, triaging and treating immune-related musculoskeletal toxicities
  • Guidance for assessing symptoms: what to look out for and what to ask
  • Understanding when to escalate and when to initiate medication and rehabilitation
  • Case study examples: what lessons have been learnt?
Jacqui Warden, Oncology Advanced Nurse Practitioner, Oxford University Hospitals NHS Foundation Trust
Questions and answers with the speakers
Sponsored presentation from Bristol Myers Squibb
Jo Christon, Associate Director Field Access, Bristol Myers Squibb
Opportunity to meet Bristol Myers Squibb in the breakout rooms
In dedicated breakout rooms, you will have the opportunity to chat directly with Bristol Myers Squibb
Screen break
Interactive discussion: Benchmark your experience of assessing and managing toxicities
  • What is your experience of managing immunotherapy toxicity?
  • How many patients receiving immunotherapy do you review each week?
  • How do you educate other professionals about side effects and toxicities of immunotherapy?
  • What escalation processes do you have in place in your team?
Feedback from interactive discussion on Benchmark your experience of assessing and managing toxicities
Identifying toxicities
Assessing and managing inflammatory ocular complications secondary to immunotherapy
  • Guidance for managing and treating immunotherapy induced inflammatory eye disease
  • Assessing the symptoms and initiating early and effective treatment
  • Learning from case study examples: what to look out for, when to investigate and when to initiate treatment
Dr Tasanee Braithwaite, Consultant Ophthalmologist, The Medical Eye Unit, Guy's and St Thomas' NHS Foundation Trust and School of Immunology and Honorary Senior Lecturer, Microbial Sciences, King’s College London
Recognising and treating endocrine toxicity secondary to IO
  • Assessing the symptoms and initiating early testing and diagnosis
  • Achieving timely referral and treatment of immunotherapy related endocrine toxicity
  • Initial management of thyroid and pituitary IO toxicity
  • Learning from case study examples: what to look out for, when to investigate and when to initiate treatment
Dr Daniel Morganstein, Consultant Endocrinologist, Chelsea and Westminster Hospital NHS Foundation Trust
Questions and answers with the speakers
Chair’s closing remarks and close of online forum

Your speaker line up:

user icon

Jacqui Warden

Oncology Advanced Nurse Practitioner
Oxford University Hospitals NHS Foundation Trust
user icon

Dr Vincent Cheung

Consultant Gastroenterologist
Oxford University Hospitals NHS Foundation Trust
user icon

Dr Tasanee Braithwaite

Consultant Ophthalmologist and Honorary Senior Lecturer
The Medical Eye Unit, Guy's and St Thomas' NHS Foundation and School of Immunology, Microbial Sciences, Trust King’s College London
user icon

Dr Daniel Morganstein

Consultant Endocrinologist
Chelsea and Westminster Hospital NHS Foundation Trust

Past attendee feedback

Following 3 hugely successful online forums, this event provided useful updates and friendly, helpful interactive discussions – but don’t take our word for it! Take a look at how past attendees have described our immunotherapy online forums over the past 2 years:

quote icon
‘Enjoyable, clear speakers, opportunity to ask questions, well organised easy to navigate’
- Ashford and St Peters Hospital, Practical Management of Immuno-Oncology (IO) Side Effects, July 2022
quote icon
‘A good mix of learning options and styles. Good interactive groups to share experience, a good way to benchmark own experience and services’
- United Lincolnshire Hospitals NHS Trust, Practical Management of Immuno-Oncology (IO) Side Effects, July 2022
quote icon
‘Well organised and wide range of interesting topics.’
- Royal Surrey NHS Foundation Trust, Practical Management of Immuno-Oncology (IO) Side Effects, July 2022
quote icon
‘Very interesting to hear about management of more uncommon side effects such as eye disease, muscoloskeltal problems’
- Worcester Royal Hospital, Practical Management of Immuno-Oncology (IO) Side Effects, July 2022
quote icon
“An excellent morning. Really enjoyed the balance between the (complex) science of checkpoint inhibitors and case studies that illustrated the importance of careful assessment and multi-professional working relationships.”
- Somerset NHS Foundation Trust, Recognising and Treating IO Side Effects, November 2021
quote icon
“Excellent, relevant, worthwhile and informative. The best online forum I have attended.”
- University Hospitals Trust Sussex NHS Foundation Trust, Recognising and Treating IO Side Effects, November 2021

Pricing structure

  • £299 + VAT for you to download and view in your own time
  • Click on 'Book Place' and complete your details

Purchase Fees

You will receive an instant payment option or invoice on completing the booking form. Once your payment has been made, you will be given the access details to view the presentations on-demand.

Certification of Attendance

A certificate for Continuing Professional Development will be given to every fully registered participant who completes the course, as a record of your continuing professional training and development.

Privacy Notice

To view the details on how your data is being collected and used, please view our Privacy policy.